Skip to content

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial.

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial. - The use of ARTISS to prevent seroma: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41295
Enrollment
121
Registered
2017-04-04
Start date
2015-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(wound) fluid collection Seroma

Interventions

Firstly, the general surgeon will perform a mastectomy. One drain will be inserted in the cavity of the amputated breast. Hereafter, the LD flap is harvested by a qualified plastic surgeon using the
latissimus dorsi
Seroma

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: All female patients older than 18 years, who will undergo a breast reconstruction with a LD flap will be included. All participating patients have to sign a written consent, before they can be included in our study.

Exclusion criteria

Exclusion criteria: Patients who are pregnant, have a pre-operative on-going infection, history of systemic anti-coagulant use, known hypersensitivity to ARTISS or postoperative haemorrhage will be excluded.

Design outcomes

Primary

MeasureTime frame
The aim of this study is to investigate the effect of ARTISS compared with conventional care (i.e., only vacuum drains after wound closure) on the formation of total volume of donor site seroma after harvesting a LD for immediate breast reconstruction. During hospitalization drainage volumes will be measured starting on day one. The drains will be removed if measured output is less than 50 mL per 24h. The duration of drainage will be recorded (i.e., in days). When the drains are removed and when the patient does not have fever, pain (VAS score = 20mL, diagnosed with clinical examination and/ or by ultrasound).

Secondary

MeasureTime frame
In addition to the formation of seroma, other complications will be taken into account. That is, the total volume of drainage during hospitalization, duration of drainage, donor-site pain, length of stay in the hospital, and costs.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)